Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CRBU stock hub

Caribou Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRBUis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

190.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRBU

In the news

Latest news · CRBU

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-83.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-39.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRBU market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001619856
Company name	Caribou Biosciences, Inc.
Country	United States
Country code	US
Cusip	142038108
Employees	97
Employees Change	-50%
Employees Change Percent	-34.01
Enterprise value	$98.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-23
Isin	US1420381089
Last refreshed	2026-05-10
Market cap	$190.6M
Market cap category	Micro-Cap
Price	$1.94
Price currency	USD
Rev Per Employee	115,494.85x
Sector	Healthcare
Sic	2836
Symbol	CRBU
Website	https://cariboubio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-69.89%
EV Sales Forward	4.14x
EV/Sales	8.83x
FCF yield	-53.32%
P/B ratio	1.84x
P/S ratio	17.02x
PS Forward	7.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-96.3M
Gross Profit Growth Q	292.95%
Net Income	$-133.2M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-1,194.05%
Profit Per Employee	$-1.4M
ROA	-34.69
Roa5y	-22.8
ROCE	-90.69
ROE	-83.46
Roe5y	-43.87
ROIC	-39.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	155.43%
Cagr3y	-24.11%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	12.96x
Revenue Growth Q	1.87x
Revenue Growth Years	1x
Revenue Growth3 Y	-8.63x
Revenue Growth5 Y	-1.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$149M
Cash	$117.6M
Current Assets	$122.4M
Current Liabilities	$19.7M
Debt	$26.9M
Debt Equity	$0.26
Equity	$102M
Liabilities	$47M
Long Term Assets	$26.6M
Long Term Liabilities	$27.3M
Net Cash	$91.7M
Net Cash By Market Cap	$48.1
Net Cash Growth	-50.77%
Net Debt Equity	$-0.9
Tangible Book Value	$102M
Tangible Book Value Per Share	$1.05
WACC	14.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.22
Net Working Capital	$-13.6M
Quick ratio	6.1
Working Capital	$102.7M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.32%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	155.26%
200-day SMA	1.93
3Y total return	-56.31%
50-day SMA	1.96
50-day SMA vs 200-day SMA	50over200
All Time High	32.65
All Time High Change	-94.06%
All Time High Date	2021-09-07
All Time Low	0.66
All Time Low Change	193.94%
All Time Low Date	2025-04-07
ATR	0.12
Beta	2.27
Beta1y	1.63
Beta2y	2.23
Ch YTD	22.01
High	1.99
High52	3.54
High52 Date	2025-11-03
High52ch	-45.12%
Low	1.89
Low52	0.73
Low52 Date	2025-05-08
Low52ch	165.72%
Ma50ch	-1.02%
Premarket Change Percent	1.06
Premarket Price	$1.9
Premarket Volume	18,615
Price vs 200-day SMA	0.31%
RSI	46.75
RSI Monthly	43.64
RSI Weekly	52.75
Sharpe ratio	1.47x
Sortino ratio	2.52
Total Return	-3.32%
Tr YTD	22.01
Tr1m	4.3%
Tr1w	3.74%
Tr3m	23.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$9
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.31
Earnings Revenue Estimate	2,245,104x
Earnings Revenue Estimate Growth	-4.59x
Operating Income	$-117.3M
Operating margin	-1,046.9
Price target	$10.75
Price Target Change	$454
Price Target Change Top	$364

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93,888,952%
Float Percent	95.55%
Shares Insiders	4.45%
Shares Institutions	40.59%
Shares Out	98,258,898
Shares Qo Q	1.4%
Shares Yo Y	3.32%
Short Float	7.21%
Short Ratio	5.85
Short Shares	6.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-112.8M
Average Volume	1,535,812.85x
Bv Per Share	1.05
CAPEX	$-389,000
Ch1m	4.3
Ch1w	3.74
Ch1y	155.3
Ch3m	23.57
Ch3y	-56.31
Ch6m	-7.18
Change	3.19%
Change From Open	2.11
Close	1.88
Days Gap	1.06
Depreciation Amortization	3,129,000
Dollar Volume	1,730,592.5
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-117.3M
EBITDA	$-114.2M
EPS	$-1.41
F Score	3
FCF	$-101.6M
FCF EV Yield	-102.73x
FCF Per Share	$-1.03
Financing CF	7,049,000
Fiscal Year End	December
Founded	2,011
Income Tax	$-550,000
Investing CF	76,842,000
Ipr	-87.88
Iprfo	-89.01
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	1.93
Ma150ch	0.52%
Ma20	2.07
Ma20ch	-6.28%
Net CF	-17,360,000
Next Earnings Date	2026-08-11
Open	1.9
Optionable	Yes
Position In Range	52.63
Post Close	1.94
Postmarket Change Percent	-0.18
Postmarket Price	$1.94
Ppne	23,479,000
Pre Close	1.88
Price Date	2026-05-08
Ptbv Ratio	1.87
Relative Volume	0.58x
Revenue	11,203,000x
SBC By Revenue	99.57x
Share Based Comp	11,155,000
Tax By Revenue	-4.91x
Tr6m	-7.18%
Us State	California
Volume	892,058

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRBU pay a dividend?

Capital-return profile for this ticker.

Performance

CRBU stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRBU?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.6%

Float: +95.6% of shares outstanding

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRBU momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

+0.3%

50/200-day relationship not available

Beta (5Y)

2.27

More volatile than the market

Sharpe ratio

1.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRBU

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRBU stock rating?

Caribou Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRBU analysis?

The full report lives at /stocks/CRBU/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRBU?

The latest report frames CRBU around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRBU page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.